More on SIGA
Data
Financials
Upcoming Events
News
Click line-items for a historical chart and %
| Research and development | 4.66M |
| Selling, general and administrative | 2.86M |
| Research and development | 6.07M |
| Patent preparation fees | 230.25K |
| Total operating expenses | 12.72M |
| Operating loss | -8.06M |
| Decrease (increase) in fair value of common stock warrants | |
| Other income, net | 30.76K |
| Loss before benefit from income taxes | -9.25M |
| Benefit from income taxes | 4.07K |
| Net income (loss) | -9.24M |
| Basic earnings (loss) per share (in dollars per share) | |
| Diluted earnings (loss) per share (in dollars per share) | |
| Weighted average shares outstanding, basic (in shares) | |
| Weighted average shares outstanding: diluted (in shares) | |
Entities mentioned with SIGA
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Dividend | View Related Stories »
- Bankruptcy | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Definitive Agreement | View Related Stories »
- Show More...
